Mochida Pharmaceutical Co., Ltd. MFY.F Stock
Mochida Pharmaceutical Co., Ltd. Price Chart
Mochida Pharmaceutical Co., Ltd. MFY.F Financial and Trading Overview
| Mochida Pharmaceutical Co., Ltd. stock price | 18.8 EUR |
| Previous Close | 20.6 EUR |
| Open | 21 EUR |
| Bid | 21 EUR x 10000 |
| Ask | 22.2 EUR x 10000 |
| Day's Range | 21 - 21 EUR |
| 52 Week Range | 20.8 - 25.2 EUR |
| Volume | 8 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 766.89M EUR |
| Beta (5Y Monthly) | 0.132183 |
| PE Ratio (TTM) | 13.725491 |
| EPS (TTM) | 0.52 EUR |
| Forward Dividend & Yield | 0.54 (2.48%) |
| Ex-Dividend Date | September 28, 2023 |
| 1y Target Est | N/A |
MFY.F Valuation Measures
| Enterprise Value | -59734507520 EUR |
| Trailing P/E | 13.725491 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0074266796 |
| Price/Book (mrq) | 0.0060516135 |
| Enterprise Value/Revenue | -0.578 |
| Enterprise Value/EBITDA | -5.343 |
Trading Information
Mochida Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.132183 |
| 52-Week Change | -2.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.2 EUR |
| 52 Week Low | 20.8 EUR |
| 50-Day Moving Average | 22.9 EUR |
| 200-Day Moving Average | 23.07 EUR |
MFY.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 36.52M |
| Float | 24.88M |
| Short Ratio | N/A |
| % Held by Insiders | 35.00% |
| % Held by Institutions | 20.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 80 |
| Trailing Annual Dividend Yield | 388.34% |
| 5 Year Average Dividend Yield | 242.00% |
| Payout Ratio | 0.3955 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 6.43% |
| Operating Margin (ttm) | 8.23% |
| Gross Margin | 53.37% |
| EBITDA Margin | 10.82% |
Management Effectiveness
| Return on Assets (ttm) | 3.30% |
| Return on Equity (ttm) | 5.20% |
Income Statement
| Revenue (ttm) | 103.26B EUR |
| Revenue Per Share (ttm) | 2778.75 EUR |
| Quarterly Revenue Growth (yoy) | -13.80% |
| Gross Profit (ttm) | 55.12B EUR |
| EBITDA | 11.18B EUR |
| Net Income Avi to Common (ttm) | 6.65B EUR |
| Diluted EPS (ttm) | 1.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 60.51B EUR |
| Total Cash Per Share (mrq) | 1656.3 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.306 |
| Book Value Per Share (mrq) | 3470.149 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 7.3B EUR |
| Levered Free Cash Flow (ttm) | 5.89B EUR |
Profile of Mochida Pharmaceutical Co., Ltd.
| Country | Germany |
| State | N/A |
| City | Tokyo |
| Address | 7, Yotsuya 1-chome |
| ZIP | 160-8515 |
| Phone | 81 3 3358 7211 |
| Website | https://www.mochida.co.jp |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals, skincare products, and biomaterial solutions in Japan. The company's therapeutic areas include cardiovascular medicine for the treatment of lifestyle diseases, such as hyperlipidemia, hypertension, and hyperuricemia; obstetrics and gynecology, including treatments for the endometriosis and dysmenorrhea, and pregnancy test kits; psychiatry, which comprises antidepressants; and gastroenterology that covers treatments for ulcerative colitis and chronic constipation; and skin care, baby care, personal care, and nursing products. It also developing drugs for the treatment of intractable diseases; and dMD-001, a medical device that is used for the treatment of articular cartilage lesions, as well as dMD-002, which is used for the treatment of cavernous nerve injury. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
Q&A For Mochida Pharmaceutical Co., Ltd. Stock
What is a current MFY.F stock price?
Mochida Pharmaceutical Co., Ltd. MFY.F stock price today per share is 18.8 EUR.
How to purchase Mochida Pharmaceutical Co., Ltd. stock?
You can buy MFY.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mochida Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Mochida Pharmaceutical Co., Ltd. is MFY.F.
Which industry does the Mochida Pharmaceutical Co., Ltd. company belong to?
The Mochida Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Mochida Pharmaceutical Co., Ltd. have in circulation?
The max supply of Mochida Pharmaceutical Co., Ltd. shares is 36.32M.
What is Mochida Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Mochida Pharmaceutical Co., Ltd. PE Ratio is 36.15384700 now.
What was Mochida Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Mochida Pharmaceutical Co., Ltd. EPS is 0.52 EUR over the trailing 12 months.
Which sector does the Mochida Pharmaceutical Co., Ltd. company belong to?
The Mochida Pharmaceutical Co., Ltd. sector is Healthcare.